Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Belite Bio, Inc. Sponsored ADR (BLTE) had Tangible Shareholders Equity of $158.07M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-14.28M |
|
-- |
|
-- |
|
$15.52M |
|
$-15.52M |
|
$1.24M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-14.28M |
|
$-15.52M |
|
$-15.52M |
|
32.08M |
|
32.08M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$159.29M |
|
-- |
|
$4.91M |
|
$164.20M |
|
-- |
|
-- |
|
-- |
|
$6.13M |
|
-- |
|
|
Tangible Shareholders Equity |
$158.07M |
$158.07M |
|
32.55M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.03% |
|
-8.69% |
|
-9.03% |
|
$4.86 |
|
-- |
|
-- |
|